Antileprotic medication classification || Type of Antileprotic drugs #shorts #medicine #pharmacology

Antileprotic drugs, used to treat leprosy (Hansen's disease), are classified into two main categories: multidrug therapy (MDT) and other ancillary medications. MDT is the cornerstone of leprosy treatment, as it prevents drug resistance and promotes effective treatment. It includes three primary drugs:

Rifampicin: Also known as rifampin, it is a bactericidal drug that kills the Mycobacterium leprae bacteria responsible for leprosy. It is a key component of MDT.

Dapsone: This bacteriostatic drug inhibits bacterial growth and is another integral part of MDT.

Clofazimine: This drug has bactericidal and anti-inflammatory properties and complements the action of rifampicin and dapsone in MDT.

Ancillary medications, used in certain cases, include:

Ofloxacin: It is sometimes used as a substitute for clofazimine and is more suitable for patients with adverse reactions to the latter.

Minocycline: An alternative to dapsone in case of intolerance or resistance.

Clarithromycin: It is used for treatment in specific cases where primary drugs are ineffective.

These drugs work in combination to attack Mycobacterium leprae from different angles, reducing the risk of resistance and improving treatment outcomes. Proper classification and administration of these drugs are essential in effectively combating leprosy while preventing its resurgence.

свернуть